Kathryn describes in great detail how pharmaceutical companies targeted Japanese citizens with an angle based on their cultural beliefs rather than science.
Largely before 1999 Japanese citizens were, it seems, oblivious to the world of antidepressants, depression was rarely discussed, due, in part, to the cultural belief system.
Around 1999 pharmaceutical companies and their genius marketing teams used a ploy that only they could get away with. An all out attack that defies belief [at least it would have once, until I started writing about pharma]
For years the Japanese people showed great courtesy [they still do to this day] by wearing surgical masks when they caught the common cold. One only has to watch news footage of Japan to witness a passer-by adorning a mask. These are pretty common-place in Japan and have been for a long time.
Japan is a nation of politeness. "Kokoro no Kaze" appears to be aimed at the very hearts of Japanese people. It's a foot in the door for the likes of companies such as GlaxoSmithKline pushing Paxil on an unsuspecting nation. Japanese pharmaceutical bosses seem to be a breed apart from other citizens of Japan. Somewhere along the line, they have been indoctrinated by the power of pharma marketing and they either believe the hype or they are in denial to merely secure a financial future for their families. Morals, it would appear, have been stripped and money-making has overpowered them. Maybe the CEO's of pharmaceutical companies in Japan need to embrace the phrase that Japan prides itself on, "The nail that sticks up gets hammered down."
From 1999 pharma publicized mild depression in Japan, the majority of citizens never even knew [utsubyo] existed let alone there being a 'cure' for it.
With pharma money and a goal of antidepressant medication, they launched this campaign to Japanese folk who up until then had inadequately addressed serious mental health conditions. Depression was tarred with the same brush as schizophrenia and treatment was available almost solely in mental institutions. 'Mild depression' did not exist, it was never a problem. The problem only occurred when the campaign was launched..."Your soul has a cold."
Up until 2004, 5 years after pharma launched their campaign in Japan, 177 books had been published about depression. Only 27 books about depression were published before the "Your soul has a cold" campaign. Depression-related doctor visits in Japan increased 46 percent from 1999 to 2003.
Japan, was, and still is in some quarters, a nation that based their beliefs on energies. Pharma changed that along with the media. To play on the minds of cultural beliefs is a genius tactic. To turn a runny nose into one's vital energy leaking should recieve an award, if only for 'The Best Award for Deception' category.
Buddhism encourages the acceptance of sadness and I guess if pharma had their way, an advertising campaign with Buddha sitting holding a packet of antidepressants would have been a road to go down. But pharma know they cannot be so blatant. "Kokoro no Kaze" was created, I believe, to chip away at the cultural beliefs that have made Japan a great country, it's a form of brainwashing rather than creating awareness.
Japan was largely ignored by pharmaceutical companies, how could they sell a product to a nation who accepted sadness into their lives and dealt with it in their own way? In the eighties Eli Lily decided against selling Prozac in Japan after market research revealed there was virtually no demand for antidepressants. So why the U-Turn?
On the 7th April 1999 the Japanese Ministry of Health and Welfare approved Luvox and Depromel (both brand names contain the active ingredient: fluvoxamine) for marketing in Japan. It was co-developed by Solvay-Meiji and Meiji Seika. Solvay-Meiji is a joint venture of Solvay SA and Meiji Seika. The marketing around this time was to run injunction with the phrase "Kokoro no Kaze" or "Your soul has a cold".
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).